ImExHS Past Earnings Performance
Past criteria checks 0/6
ImExHS has been growing earnings at an average annual rate of 13.2%, while the Healthcare Services industry saw earnings growing at 13% annually. Revenues have been growing at an average rate of 22.8% per year.
Key information
13.2%
Earnings growth rate
30.6%
EPS growth rate
Healthcare Services Industry Growth | 42.6% |
Revenue growth rate | 22.8% |
Return on equity | -22.7% |
Net Margin | -13.7% |
Last Earnings Update | 30 Jun 2024 |
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How ImExHS makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
30 Jun 24 | 25 | -3 | 8 | 2 |
31 Mar 24 | 22 | -4 | 7 | 2 |
31 Dec 23 | 20 | -4 | 6 | 1 |
30 Sep 23 | 18 | -4 | 6 | 1 |
30 Jun 23 | 17 | -4 | 5 | 1 |
31 Mar 23 | 17 | -3 | 6 | 1 |
31 Dec 22 | 17 | -3 | 6 | 2 |
30 Sep 22 | 18 | -3 | 6 | 2 |
30 Jun 22 | 18 | -4 | 6 | 1 |
31 Mar 22 | 16 | -4 | 6 | 1 |
31 Dec 21 | 13 | -5 | 6 | 1 |
30 Sep 21 | 13 | -4 | 6 | 1 |
30 Jun 21 | 12 | -4 | 6 | 1 |
31 Mar 21 | 11 | -4 | 5 | 1 |
31 Dec 20 | 11 | -4 | 5 | 1 |
30 Sep 20 | 10 | -5 | 5 | 1 |
30 Jun 20 | 10 | -6 | 5 | 1 |
31 Mar 20 | 9 | -6 | 5 | 2 |
31 Dec 19 | 8 | -6 | 5 | 2 |
30 Sep 19 | 7 | -6 | 4 | 2 |
30 Jun 19 | 7 | -7 | 4 | 2 |
31 Mar 19 | 6 | -6 | 3 | 2 |
31 Dec 18 | 6 | -5 | 3 | 1 |
30 Sep 18 | 5 | -3 | 2 | 1 |
30 Jun 18 | 4 | -1 | 1 | 0 |
31 Mar 18 | 4 | -1 | 1 | 0 |
31 Dec 17 | 4 | -1 | 1 | 0 |
31 Dec 16 | 3 | 0 | 1 | 0 |
31 Dec 15 | 4 | 0 | 1 | 0 |
Quality Earnings: IME is currently unprofitable.
Growing Profit Margin: IME is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: IME is unprofitable, but has reduced losses over the past 5 years at a rate of 13.2% per year.
Accelerating Growth: Unable to compare IME's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: IME is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare Services industry (12.7%).
Return on Equity
High ROE: IME has a negative Return on Equity (-22.65%), as it is currently unprofitable.